FDA-approved drug against Ebola

FDA-approved drug against Ebola
Recent research reveals that gamma interferon, an FDA-approved drug when given as an antiviral therapy either before or after the virus’ exposure may prevent Ebola infection. Gamma interferon is believed to block the infection by targeting the macrophages (the initial cells targeted by virus) where the virus replicates. The study carried in mice suggests that this drug could be used as a prophylaxis and post-exposure treatment against Ebola.
How to cite this article:
Hameedunissa Begum A. FDA-approved drug against Ebola. BioLim O-Media. 31 March, 2017. 5(3).
Available from: http://archive.biolim.org/omedia/read/BOMA0209.